NuVasive Leading Sponsor Of IMAST 2017 And Hosting Workshops Featuring Advanced Technologies

SAN DIEGO, CA – July 10, 2017 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a leading sponsor of the Scoliosis Research Society’s (SRS) International Meeting On Advanced Spine Techniques (IMAST) being held July 12-15, 2017 in Cape Town, South Africa. NuVasive will host hands-on workshops featuring the latest advanced technologies in treating scoliosis.

NuVasive workshops at the event will include the MAGEC® system, which utilizes innovative magnetic technology within adjustable growing rods to treat early-onset scoliosis (EOS); the Company’s flagship XLIF® procedure, the only lateral approach procedure proven by over 10 years of clinical evidence; and the Integrated Global Alignment® (iGA) platform.

NuVasive will showcase spine’s fastest growing spinal deformity portfolio on the show floor at IMAST 2017, including the iGA platform. The platform is comprised of procedurally based technologies designed to enhance clinical and economic outcomes by increasing the predictability of achieving global alignment in all spinal procedures.

NuVasive recently launched the ‘Embracing the Journey Together’ initiative, which includes pediatric spinal deformity research, education and spinal deformity event support, supporting leading surgeons as they educate surgeons around the world.

NuVasive 2017 IMAST Participation Details

NuVasive will showcase its market-leading, procedurally-integrated technologies at NuVasive Booth #33 on the IMAST exhibit floor. NuVasive hands-on workshops include:

XLIF: Designed. Proven. Transforming.

Juan S. Uribe, M.D., Ian Zondagh, M.D.

Wednesday, July 12 at 17:00-19:00

Meeting Room 1.43

MAGEC Masters Roundtable: Surpassing Surgical and Post-operative Challenges

Ettienne Coetzee, M.D., David Marks, M.D., Suken Shah, M.D., Muharrem Yazici, M.D.

Thursday, July 13 at 12:30-13:30

Meeting Room 1.43

iGA: A comprehensive Approach to Planning and Achieving Integrated Global Alignment

Christopher I. Shaffrey, M.D., Juan S. Uribe, M.D.

Friday, July 14 at 12:00-13:00

Meeting Room 1.43

Visit here for more details and schedule of events.

About NuVasive

NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company’s portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

# # #

Investor Contact:
Suzanne Hatcher
NuVasive, Inc.
858-458-2240
[email protected]

 

Media Contact:
Stefanie Mazer
NuVasive, Inc.
858-320-5243
[email protected]

Previous Post